Nurix TherapeuticsNRIX
那斯達克 · USD
23.38
-0.36
(-1.52%)
收盤 07/25 03:59 (UTC+8)
07/25 03:59 (UTC+8)
Nurix TherapeuticsNRIX
23.38
-0.36
(-1.52%)
財務數據
損益表
- 0.17
- 0.12
- 0.13
- 0.13
- 0.18
- 0.44
- 0.08
- 0.14
- 0.06
- 0.09
- 9.41
- -27.09
- 4.10
- 5.53
- 38.91
- 138.75
- -82.08
- 71.99
- -53.95
- 44.64
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 9,043 | 6,252 | 13,577 | 7,894 | 44,056 | 18,453 | 13,284 | 12,588 | 12,092 | 16,585 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 9,043 | 6,252 | 13,577 | 7,894 | 44,056 | 18,453 | 13,284 | 12,588 | 12,092 | 16,585 |
營業費用 | 103,247 | 98,747 | 96,672 | 99,279 | 92,378 | 81,317 | - | - | 60,632 | 61,804 |
研發費用 | 87,652 | 84,137 | 83,024 | 86,120 | 78,096 | 69,663 | 67,224 | 55,481 | 48,922 | 50,005 |
推銷及管理費用 | 15,595 | 14,610 | 13,648 | 13,159 | 14,282 | 11,654 | 10,717 | 11,718 | 11,710 | 11,799 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -94,204 | -92,495 | -83,095 | -91,385 | -48,322 | -62,864 | -64,657 | -54,611 | -48,540 | -45,219 |
其他收入及費用 | 4,398 | 5,321 | 4,874 | 4,964 | 5,618 | 6,513 | 6,116 | 5,737 | 4,084 | 3,791 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -89,806 | -87,174 | -78,221 | -86,421 | -42,704 | -56,351 | -58,541 | -48,874 | -44,456 | -41,428 |
所得稅 | -271 | - | - | - | 760 | - | 8 | 82 | 90 | 90 |
稅後純益 | -89,535 | -87,174 | -78,221 | -86,421 | -43,464 | -56,351 | -58,549 | -48,956 | -44,546 | -41,518 |
基本每股稅後盈餘(元) | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 |
稀釋每股稅後盈餘(元) | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 | -0.67 | -0.75 | -0.66 | -0.71 | -0.76 |
基本平均股數(千股) | 111084.00 | 110071.00 | 95089.00 | 84159.00 | 83882.00 | 83560.00 | 78410.00 | 72779.00 | 62377.00 | 54903.00 |
稀釋平均股數(千股) | 111084.00 | 110071.00 | 95089.00 | 84159.00 | 83882.00 | 83560.00 | 78410.00 | 72779.00 | 62377.00 | 54903.00 |
還原基本每股稅後盈餘(元) | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 |
還原稀釋每股稅後盈餘(元) | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 | -0.67 | -0.75 | -0.66 | -0.71 | -0.76 |
還原基本平均股數(千股) | 111,084 | 110,071 | 95,089 | 84,159 | 83,882 | 83,560 | 78,410 | 72,779 | 62,377 | 54,903 |
還原稀釋平均股數(千股) | 111,084 | 110,071 | 95,089 | 84,159 | 83,882 | 83,560 | 78,410 | 72,779 | 62,377 | 54,903 |
EBITDA(千元) | -87,513 | -85,376 | -75,457 | -83,618 | -40,308 | -55,780 | -57,731 | -48,434 | -42,524 | -39,470 |